Max MyHealth Digital Platform & CSR Initiatives

3 MAX Strong track record of successful acquisitions Healthcare • • Management team has done multiple successful acquisitions including BLK, Nanavati and Max Healthcare Adequate headroom driven by strong free cash flows and low leverage to pursue M&A even after spend on brownfield and greenfield expansions FY23 FY22 FY21 FY20 FY19 348 590 Case study on Max acquisition and turnaround EBITDA (INR Cr) 636 Merger of Max Healthcare and Radiant effective from June 2020 Demonstrated EBITDA margins of 19.2% in Q4 (excl. last 10 days of March due to COVID) 1,305 EBITDA ROCE* Margin 1,636 27.7% 33.1% 26.2% 28.8% 17.5% 14.3% 14.7% 11.1% 9.7% 5.4% Performance improvement from FY19 to FY23 largely driven by: • . ~INR 330 Cr impact on EBITDA driven by structural cost initiatives as well as merger synergies, with ~INR 140 Cr flowing in EBITDA in FY20, ~INR 73 Cr flowing in EBITDA in FY21 and balance in FY22 Significant growth in high-end tertiary and quaternary procedures with hiring of new senior clinical teams and deployment of latest medical technology across our Network, including 17 robotic systems *Combined performance of Max Healthcare and Radiant; Excludes COVID-19 vaccination & related antibody tests EBITDA 20 20

View entire presentation